07/17/2019
3:57 PM | AzurRx BioPharma (Filer)
| Form 424B5
|  |
07/10/2019
1:36 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2019
5:46 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2019
5:42 PM | AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2019
5:41 PM | AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2019
5:37 PM | AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
11:15 PM | AzurRx BioPharma (Filer)
| Form EFFECT
| |
06/21/2019
7:10 PM | AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
| Form 4/A
| |
06/21/2019
7:08 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4/A
| |
06/21/2019
7:04 PM | AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
| Form 4/A
| |
06/21/2019
7:01 PM | AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
| Form 4/A
| |
06/21/2019
4:25 PM | AzurRx BioPharma (Filer)
| Form S-3/A
| |
06/21/2019
4:23 PM | AzurRx BioPharma (Filer)
| Form 424B3
| |
06/17/2019
8:51 PM | AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
8:50 PM | AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
8:49 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
8:48 PM | AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2019
11:19 PM | AzurRx BioPharma (Filer)
| Form EFFECT
| |
06/07/2019
4:00 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2019
8:36 AM | AzurRx BioPharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/04/2019
8:45 PM | AzurRx BioPharma (Filer)
| Form S-3/A
| |
05/23/2019
4:01 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2019
4:00 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2019
4:17 PM | AzurRx BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2019
3:05 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
8:28 AM | AzurRx BioPharma (Filer)
| Form 424B5
| |
05/07/2019
12:03 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
4:24 PM | AzurRx BioPharma (Filer)
| Form 10-K/A
| |
04/29/2019
7:27 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2019
7:24 PM | AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2019
7:22 PM | AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2019
7:20 PM | AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2019
2:15 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2019
8:50 AM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2019
7:56 AM | AzurRx BioPharma (Filer)
| Form 424B5
| |
04/01/2019
3:41 PM | AzurRx BioPharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2019
4:00 PM | AzurRx BioPharma (Subject)
Ross Edmund Burke Jr. (Filed by)
| Form SC 13D/A
| |
02/20/2019
7:29 AM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2019
8:45 PM | AzurRx BioPharma (Issuer)
Ross Edmund Burke Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
10:23 AM | AzurRx BioPharma (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A
| |
02/13/2019
3:42 PM | AzurRx BioPharma (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A
| |
01/29/2019
2:44 PM | AzurRx BioPharma (Subject)
BALK MATTHEW (Filed by)
| Form SC 13G/A
| |
01/07/2019
5:49 PM | AzurRx BioPharma (Issuer)
Ross Edmund Burke Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
5:47 PM | AzurRx BioPharma (Issuer)
Spoor Johan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
5:44 PM | AzurRx BioPharma (Issuer)
Shenouda Maged (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
5:03 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
5:01 PM | AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:58 PM | AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:55 PM | AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2018
4:07 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2018
3:39 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2018
8:37 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2018
3:41 PM | AzurRx BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2018
12:46 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2018
2:27 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2018
3:07 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2018
7:05 PM | AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2018
7:03 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2018
6:59 PM | AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2018
6:56 PM | AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2018
3:36 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2018
3:05 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2018
4:22 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2018
5:24 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2018
5:22 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4/A
| |
07/23/2018
4:05 PM | AzurRx BioPharma (Filer)
| Form DEF 14A
| |
07/19/2018
12:20 PM | AzurRx BioPharma (Issuer)
Pennington James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2018
10:57 AM | AzurRx BioPharma (Issuer)
Dupret Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2018
7:57 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2018
8:08 PM | AzurRx BioPharma (Issuer)
Spoor Johan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
6:23 PM | AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
6:22 PM | AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
6:20 PM | AzurRx BioPharma (Issuer)
Shenouda Maged (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
6:18 PM | AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
3:47 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2018
11:15 PM | AzurRx BioPharma (Filer)
| Form EFFECT
| |
07/11/2018
12:27 PM | AzurRx BioPharma (Filer)
| Form S-3/A
| |
07/03/2018
4:16 PM | AzurRx BioPharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/04/2018
5:00 PM | AzurRx BioPharma (Issuer)
Pennington James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/01/2018
4:28 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2018
4:14 PM | AzurRx BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2018
2:32 PM | AzurRx BioPharma (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G
| |
05/11/2018
12:35 PM | AzurRx BioPharma (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G
| |
05/01/2018
8:12 AM | AzurRx BioPharma (Filer)
| Form S-3MEF
| |
04/23/2018
3:15 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/20/2018
5:55 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2018
3:17 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2018
3:16 PM | AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2018
3:14 PM | AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2018
4:07 PM | AzurRx BioPharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2018
4:31 PM | AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/13/2018
4:29 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/13/2018
4:20 PM | AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/13/2018
4:18 PM | AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/19/2018
4:25 PM | AzurRx BioPharma (Filer)
| Form 424B3
| |
01/17/2018
5:23 AM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2018
5:13 PM | AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
6:30 AM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2018
4:05 PM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2017
8:44 AM | AzurRx BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
